中国现代医生杂志欢迎您.   今天是:          
高志洪1 钱丽萍2▲.TSGF、SCC-Ag、CA125水平对宫颈癌病情及预后的评估价值[J].中国现代医生,2021,59(27):13-16+33
TSGF、SCC-Ag、CA125水平对宫颈癌病情及预后的评估价值
The evaluation value of TSGF,SCC-Ag,CA125 levels on the condition and prognosis of cervical cancer
  
DOI:
中文关键词:  宫颈癌  TSGF  SCC-Ag  CA125  预后
英文关键词:Cervical cancer  TSGF  SCC-Ag  CA125  Prognosis
基金项目:
作者单位
高志洪1 钱丽萍2▲ 1.江苏大学附属武进医院检验科江苏常州 2130002.江苏省常州市新北区妇幼保健计划生育服务中心江苏常州213000 
摘要点击次数: 183
全文下载次数: 642
中文摘要:
      目的 探讨肿瘤特异性生长因子(TSGF)、鳞状上皮细胞癌抗原(SCC-Ag)、糖类抗原-125(CA125)水平对宫颈癌病情监测及预后评估的价值。方法 选取我院2016 年2 月至2017 年3 月收治的86例宫颈癌患者(宫颈癌组)、46例宫颈上皮内瘤变患者(良性组)和40例健康体检女性(对照组)作为研究对象,检测三组受试者血清TSGF、SCC-Ag、CA125的水平。并在结束治疗后随访3 年,根据肿瘤是否复发,将86例宫颈癌患者分为复发组22例和未复发组64例,比较两组TSGF、SCC-Ag、CA125水平,分析以上3 项指标单项及联合检测对宫颈癌病情及预后的评估价值。结果 宫颈癌组血清TSGF、SCC-Ag、CA125水平均高于良性组和对照组,差异有统计学意义(P<0.05);随访3 年内复发组血清TSGF、SCC-Ag、CA125水平均明显高于未复发组,差异有统计学意义(P<0.05)。Spearman 相关性分析显示,患者血清TSGF、SCC-Ag、CA125水平与治疗后3 年内复发呈正相关(r=0.536、0.328、0.745,P<0.05)。ROC 曲线分析显示,患者血清TSGF+SCC-Ag+CA125水平联合预测其3 年内肿瘤复发的灵敏度、特异度及准确性均较高,差异有统计学意义(P<0.05)。结论 血清TSGF、SCC-Ag、CA125水平有助于准确地监测宫颈癌患者的病情程度,三项指标联合检测可作为患者预后的评估指标,具有一定的临床价值。
英文摘要:
      Objective To explore the value of tumor specific growth factor (TSGF),squamous cell carcinoma antigen(SCC-Ag),carbohydrate antigen-125 (CA125) levels in cervical cancer monitoring and prognostic evaluation.Methods A total of 86 patients with cervical cancer (cervical cancer group),46 patients with cervical intraepithelial neoplasia(benign group) and 40 healthy women (control group) who were admitted to our hospital from February 2016 to March 2017 as the research subjects.The levels of serum TSGF,SCC-Ag,and CA125 in the three groups were detected.After the treatment,the patients were followed up for three years.According to whether the tumor recurred,86 patients with cervical cancer were divided into the recurrence group of 22 cases and the non-recurrence group of 64 cases.The levels of TSGF,SCC-Ag and CA125 between the two groups were compared.The evaluation value of single and combined tests of the above three indicators on the condition and prognosis of cervical cancer were analyzed.Results The serum TSGF,SCC-Ag,CA125 levels in cervical cancer group were higher than those in benign group and control group,and the difference was statistically significant(P<0.05).The serum TSGF,SCC-Ag,CA125 levels in recurrence group within three years of follow-up were significantly higher than the non-recurrence group,and the difference was statistically significant(P<0.05).Spearman correlation analysis showed that serum TSGF,SCC-Ag,and CA125 levels were positively correlated with recurrence within three years after treatment(r=0.536,0.328,0.745,P<0.05).ROC curve analysis showed that the sensitivity,specificity,and accuracy of the combination of serum TSGF+SCC-Ag+CA125 levels in predicting tumor recurrence within three years were higher,and the difference was statistically significant (P<0.05).Conclusion Serum TSGF,SCC-Ag,and CA125 levels are helpful to accurately monitor the severity of cervical cancer patients.The combined detection of the three indicators can be used as an evaluation indicator for the prognosis of patients and has certain clinical value.
查看全文  查看/发表评论  下载PDF阅读器
关闭
    • 关键词 :
    • 中国医生
    • 中国现代医生
    • 中国临床医生
    • 中国医师
    • 主任医师
    • 中国医学
    • 中华医学
    • 中国医院
    • 中国医药
    • 中国医疗
    • 现代医生
    • 现代医学
    • 现代医药
    • 现代医院
    • 现代药物
    • 现代护理
    • 现代临床
    • 医学杂志
    • 药学杂志
    • 医药杂志
    • 医生杂志
    • 医师杂志
    • 医疗杂志
    • 医药期刊
    • 医学期刊
    • 医药卫生期刊
    • 医药论文
    • 医学论文
    • 科研论文
    • 职称论文
    function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=A32BE29EFE91E871BF96B7E3B0B3955DD6A66B0A24176E74B4B2E5D90E33D232DF03CBEB0CB12E92276253BAC4B57D273A83AD91BE1CA28EF0769C98DE000A86D57C86E2D638E6271D9165C7C9CC9CE2F78FC8DFB6E03A98D83FEDE8811352AE212A344368139935&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=8EDAEC11C165015425CEEA15366CB0A7&yid=9475FABC7A03F4AB&aid=&vid=&iid=DB817633AA4F79B9&sid=FC0714F8D2EB605D&eid=51D259FA7D0B428D&fileno=2023021&flag=1&is_more=0">